Vanda Pharmaceuticals General Counsel Timothy Williams resigns, effective Apr 10, 2026

Vanda Pharmaceuticals Inc.

Timothy Williams resigns as SVP, General Counsel and Secretary, effective April 10, 2026.
No successor or interim replacement announced; search process not disclosed.
Resignation is to pursue other endeavors; no conflict or disagreement noted.

item 5.02

Vanda Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-023222

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.